670
Views
0
CrossRef citations to date
0
Altmetric
Review

Fifty years of paracetamol (acetaminophen) poisoning: the development of risk assessment and treatment 1973–2023 with particular focus on contributions published from Edinburgh and Denver

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1020-1031 | Received 04 Oct 2023, Accepted 06 Dec 2023, Published online: 10 Jan 2024

References

  • Davidson DG, Eastham WN. Acute liver necrosis following overdose of paracetamol. Br Med J. 1966;2(5512):497–499. doi: 10.1136/bmj.2.5512.497.
  • Thomson JS, Prescott LF. Liver damage and impaired glucose tolerance after paracetamol overdosage. Br Med J. 1966;2(5512):506–507. doi: 10.1136/bmj.2.5512.506.
  • Bertolini A, Ferrari A, Ottani A, et al. Paracetamol: new vistas of an old drug. CNS Drug Rev. 2006;12(3–4):250–275. doi: 10.1111/j.1527-3458.2006.00250.x.
  • Prescott LF. Paracetamol (acetaminophen) poisoning: the early years. Br J Clin Pharmacol. 2024;90:127–134. doi: 10.1111/bcp.15903.
  • Rumack BH, Bateman DN. Acetaminophen and acetylcysteine dose and duration: past, present and future. Clin Toxicol (Phila). 2012;50(2):91–98. doi: 10.3109/15563650.2012.659252.
  • Proudfoot AT, Wright N. Acute paracetamol poisoning. Br Med J. 1970;3(5722):557–558. doi: 10.1136/bmj.3.5722.557.
  • Prescott LF, Roscoe P, Wright N, et al. Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. Lancet. 1971;1(7698):519–522. doi: 10.1016/s0140-6736(71)91125-1.
  • Rumack BH, Matthew H. Acetaminophen poisoning and toxicity. Paediatrics. 1975;55(6):871–876. doi: 10.1542/peds.55.6.871.
  • Prescott LF. The chief scientist reports … prevention of hepatic necrosis following paracetamol overdosage. Health Bull. 1978;36(4):204–212.
  • Reid WD, Christie B, Krishna G, et al. Bromobenzene metabolism and hepatic necrosis. Pharmacology. 1971;6(1):41–55. doi: 10.1159/000136226.
  • Jollow D. Acetaminophen-induced hepatic necrosis: a reminiscence. Drug Metab Dispos. 2023; DMD-COM-2023-001278. Online ahead of print. doi: 10.1124/dmd.123.001278.
  • Mitchell JR, Jollow DJ, Potter WZ, et al. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther. 1973;187(1):211–217.
  • Jollow DJ, Mitchell JR, Potter WZ, et al. Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther. 1973;187(1):195–202.
  • Mitchell JR, Thorgeirsson SS, Potter WZ, et al. Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy. Clin Pharmacol Ther. 1974;16(4):676–684. doi: 10.1002/cpt1974164676.
  • Piperno E, Berssenbruegge DA. Reversal of experimental paracetamol toxicosis with N-acetylcysteine. Lancet. 1976;2(7988):738–739. doi: 10.1016/s0140-6736(76)90030-1.
  • Koch-Weser J. Acetaminophen. N Engl J Med. 1976;295(23):1297–1300. doi: 10.1056/NEJM197612022952306.
  • Prescott LF, Park J, Proudfoot AT. Cysteamine for paracetamol poisoning. Lancet. 1976;1(7955):357. doi: 10.1016/s0140-6736(76)90105-7.
  • Prescott LF, Newton RW, Swainson CP, et al. Successful treatment of severe paracetamol overdosage with cysteamine. Lancet. 1974;1(7858):588–592. doi: 10.1016/s0140-6736(74)92649-x.
  • Douglas AP, Hamlyn AN, James O. Controlled trial of cysteamine in paracetamol (acetaminophen) poisoning. Lancet. 1976;1(7951):111–115. doi: 10.1016/s0140-6736(76)93154-8.
  • Prescott LF, Wright N. BAL in paracetamol poisoning. Lancet. 1974;2(7884):833–834. doi: 10.1016/s0140-6736(74)91092-7.
  • Prescott LF, Sutherland GR, Park J, et al. Cysteamine, methionine, and penicillamine in the treatment of paracetamol poisoning. Lancet. 1976;2(7977):109–113. doi: 10.1016/s0140-6736(76)92842-7.
  • Vale JA, Meredith TJ, Goulding R. Treatment of acetaminophen poisoning. The use of oral methionine. Arch Intern Med. 1981;141(3):394–396. doi: 10.1001/archinte.141.3.394.
  • Prescott LF, Park J, Ballantyne A, et al. Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. Lancet. 1977;2(8035):432–434. doi: 10.1016/s0140-6736(77)90612-2.
  • Prescott LF, Illingworth RN, Critchley JA, et al. Intravenous N-acetylcysteine: the treatment of choice for paracetamol poisoning. Br Med J. 1979;2(6198):1097–1100. doi: 10.1136/bmj.2.6198.1097.
  • Prescott LF, Matthew H, Todd J. Cysteamine for paracetamol overdosage. Lancet. 1974;303(7864):998. doi: 10.1016/S0140-6736(74)91316-6.
  • Rumack BH, Peterson RC, Koch GG, et al. Acetaminophen overdose 662 cases with evaluation of oral acetylcysteine treatment. Arch Intern Med. 1981;141(3 Spec No):380–385.
  • Blair D, Rumack BH. Acetaminophen in serum and plasma by high-pressure liquid chromatography: a micro-scale method. Clin Chem. 1977;23(4):743–744. doi: 10.1093/clinchem/23.4.743.
  • Rumack BH, Peterson RG. Acetaminophen overdose: incidence, diagnosis, and management in 416 patients. Pediatrics. 1978;62(5 Pt 2 Suppl):898–903. doi: 10.1542/peds.62.5S.898.
  • Peterson RG, Rumack B. Treating acute acetaminophen poisoning with acetylcysteine. JAMA. 1977;237(22):2406–2407.
  • Prescott LF. Treatment of severe acetaminophen poisoning with intravenous acetylcysteine. Arch Intern Med. 1981;141(3):386–389. doi: 10.1001/archinte.1981.00340030118021.
  • Piperno E, Mosher AH, Berssenbrugge DA, et al. Pathophysiology of acetaminophen overdosage toxicity: implications for management. Pediatrics. 1978;62(5 Pt 2 Suppl):880–889.
  • Rumack BH, John Meredith T, Peterson RG, et al. Panel discussion management of acetaminophen overdose. Arch Intern Med. 1981;141(3):401–403. doi: 10.1001/archinte.1981.00340030133025.
  • Smilkstein MJ, Knapp GL, Kulig KW, et al. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med. 1988;319(24):1557–1562. doi: 10.1056/NEJM198812153192401.
  • Rumack BH. Acetaminophen hepatotoxicity: the first 35 years. J Toxicol Clin Toxicol. 2002;40(1):3–20. doi: 10.1081/clt-120002882.
  • Peterson RG, Rumack BH. Pharmacokinetics of acetaminophen in children. Pediatrics. 1978;62(5s):877–879. doi: 10.1542/peds.62.5S.877.
  • Rumack BH. Acetaminophen overdose in young children. Treatment and effects of alcohol and other additional ingestants in 417 cases. Am J Dis Child. 1984;138(5):428–433. doi: 10.1001/archpedi.1984.02140430006003.
  • Riggs BS, Bronstein AC, Kulig K, et al. Acute acetaminophen overdose during pregnancy. Obs Gynecol. 1989;74:247–253.
  • Horowitz RS, Dart RC, Jarvie DR, et al. Placental transfer of N-acetylcysteine following human maternal acetaminophen toxicity. J Toxicol Clin Toxicol. 1997;35(5):447–451. doi: 10.3109/15563659709001226.
  • Prescott LF. Paracetamol, alcohol and the liver. Br J Clin Pharmacol. 2000;49(4):291–301. doi: 10.1046/j.1365-2125.2000.00167.x.
  • Roberts BJ, Song B-J, Soh Y, et al. Ethanol induces CYP2E1 by protein stabilization. Role of ubiquitin conjugation in the rapid degradation of CYP2E1. J Biol Chem. 1995;270(50):29632–29635. doi: 10.1074/jbc.270.50.29632.
  • Dart RC, Green JL, Kuffner EK, et al. The effects of paracetamol (acetaminophen) on hepatic tests in patients who chronically abuse alcohol - A randomized study. Aliment Pharmacol Ther. 2010;32(3):478–486. doi: 10.1111/j.1365-2036.2010.04364.x.
  • Rumack B, Heard K, Green J, et al. Effect of therapeutic doses of acetaminophen (up to 4 g/day) on serum alanine aminotransferase levels in subjects consuming ethanol: systematic review and meta-analysis of randomized controlled trials. Pharmacotherapy. 2012;32(9):784–791. doi: 10.1002/j.1875-9114.2012.01122.x.
  • Keays R, Harrison PM, Wendon JA, et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ. 1991;303(6809):1026–1029. doi: 10.1136/bmj.303.6809.1026.
  • Yarema MC, Johnson DW, Berlin RJ, et al. Comparison of the 20-hour intravenous and 72-hour oral acetylcysteine protocols for the treatment of acute acetaminophen poisoning. Ann Emerg Med. 2009;54(4):606–614. doi: 10.1016/j.annemergmed.2009.05.010.
  • Cairney DG, Beckwith HKS, Al-Hourani K, et al. Plasma paracetamol concentration at hospital presentation has a dose-dependent relationship with liver injury despite prompt treatment with intravenous acetylcysteine. Clin Toxicol. 2016;54(5):405–410. doi: 10.3109/15563650.2016.1159309.
  • Hendrickson RG. What is the most appropriate dose of N-acetylcysteine after massive acetaminophen overdose? Clin Toxicol. 2019;57(8):686–691. doi: 10.1080/15563650.2019.1579914.
  • Marks DJB, Dargan PI, Archer JRH, et al. Outcomes from massive paracetamol overdose: a retrospective observational study. Br J Clin Pharmacol. 2017;83(6):1263–1272. doi: 10.1111/bcp.13214.
  • Walton NG, Mann TA, Shaw KM. Anaphylactoid reaction to N-acetylcysteine. Lancet. 1979;2(8155):1298. doi: 10.1016/s0140-6736(79)92306-7.
  • Bateman DN, Woodhouse KW, Rawlins MD. Adverse reactions to N-acetylcysteine. Hum Toxicol. 1984;3(5):393–398. doi: 10.1177/096032718400300504.
  • Pakravan N, Waring WS, Sharma S, et al. Risk factors and mechanisms of anaphylactoid reactions to acetylcysteine in acetaminophen overdose. Clin Toxicol. 2008;46(8):697–702. doi: 10.1080/15563650802245497.
  • Waring WS, Pettie JM, Dow MA, et al. Paracetamol appears to protect against N-acetylcysteine-induced anaphylactoid reactions. Clin Toxicol. 2006;44:441–442.
  • Schmidt LE. Identification of patients at risk of anaphylactoid reactions to N-acetylcysteine in the treatment of paracetamol overdose. Clin Toxicol. 2013;51(6):467–472. doi: 10.3109/15563650.2013.799677.
  • Sandilands EA, Bateman DN. Adverse reactions associated with acetylcysteine. Clin Toxicol. 2009;47(2):81–88. doi: 10.1080/15563650802665587.
  • Coulson J, Thompson JP. Paracetamol (acetaminophen) attenuates in vitro mast cell and peripheral blood mononucleocyte cell histamine release induced by N-acetylcysteine. Clin Toxicol. 2010;48(2):111–114. doi: 10.3109/15563650903520959.
  • Bateman DN, Carroll R, Pettie J, et al. Effect of the Uk’s revised paracetamol poisoning management guidelines on admissions, adverse reactions and costs of treatment. Br J Clin Pharmacol. 2014;78(3):610–618. doi: 10.1111/bcp.12362.
  • Chiew A, Gluud C, Brok J, et al. Interventions for paracetamol (acetaminophen) overdose. Cochrane Database Syst Rev. 2018;(2):CD003328. doi: 10.1002/14651858.CD003328.pub3.
  • Johnson MT, Mccammon CA, Mullins ME, et al. Evaluation of a simplified n-acetylcysteine dosing regimen for the treatment of acetaminophen toxicity. Ann Pharmacother. 2011;45(6):713–720. doi: 10.1345/aph.1P613.
  • McNulty R, Lim J, Chandru P, et al. Fewer adverse effects with a modified 2-bag intravenous acetylcysteine protocol compared to the traditional 3-bag protocol in paracetamol overdose. Clin Toxicol. 2018;56(7):618–621. doi: 10.1080/15563650.2017.1408812.
  • Schmidt LE, Rasmussen DN, Petersen TS, et al. Fewer adverse effects associated with a modified two-bag intravenous acetylcysteine protocol compared to traditional three-bag regimen in paracetamol overdose. Clin Toxicol. 2018;56(11):1128–1134. doi: 10.1080/15563650.2018.1475672.
  • Wong A, Isbister G, McNulty R, et al. Efficacy of a two bag acetylcysteine regimen to treat paracetamol overdose (2NAC study). EClinicalMedicine. 2020;20:100288. doi: 10.1016/j.eclinm.2020.100288.
  • O'Callaghan C, Graudins A, Wong A. A two-bag acetylcysteine regimen is associated with shorter delays and interruptions in the treatment of paracetamol overdose. Clin Toxicol. 2021;60(3):319–323. doi: 10.1080/15563650.2021.1966027.
  • Bateman DN, Dear JW, Thanacoody HKR, et al. Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomized controlled trial. Lancet. 2014;383(9918):697–704. doi: 10.1016/S0140-6736(13)62062-0.
  • Pettie JM, Caparrotta TM, Hunter RW, et al. Safety and efficacy of the SNAP 12-hour acetylcysteine regimen for the treatment of paracetamol overdose. EClinicalMedicine. 2019;11:11–17. doi: 10.1016/j.eclinm.2019.04.005.
  • Wong A, McNulty R, Taylor D, et al. The NACSTOP trial: a multicenter, cluster-controlled trial of early cessation of acetylcysteine in acetaminophen overdose. Hepatology. 2019;69(2):774–784. doi: 10.1002/hep.30224.
  • Hoyte C, Dart RC. Transition to two-bag intravenous acetylcysteine for acetaminophen overdose: a poison center’s experience. Clin Toxicol. 2019;57(3):217–218. doi: 10.1080/15563650.2018.1510127.
  • Mullins ME, Yarema MC, Sivilotti MLA, et al. Comment on “transition to two-bag intravenous acetylcysteine for acetaminophen overdose. Clin Toxicol. 2020;58(5):433–435. doi: 10.1080/15563650.2019.1649418.
  • Dart RC, Rumack BH. Patient-tailored acetylcysteine administration. Ann Emerg Med. 2007;50(3):280–281. doi: 10.1016/j.annemergmed.2007.01.015.
  • Doyon S, Klein-Schwartz W, Lee S, et al. Fatalities involving acetaminophen combination products reported to United States poison centers. Clin Toxicol. 2013;51(10):941–948. doi: 10.3109/15563650.2013.848282.
  • Dart RC, Mullins ME, Matoushek T, et al. Management of acetaminophen poisoning in the US and Canada: a consensus statement. JAMA Netw Open. 2023;6(8):e2327739. doi: 10.1001/jamanetworkopen.2023.27739.
  • Chiew AL, Isbister GK, Kirby KA, et al. Massive paracetamol overdose: an observational study of the effect of activated charcoal and increased acetylcysteine dose (ATOM-2). Clin Toxicol. 2017;55(10):1055–1065. doi: 10.1080/15563650.2017.1334915.
  • Thanacoody HKR. Large paracetamol overdose – higher dose NAC is NOT required. Br J Clin Pharmacol. 2023;89(1):39–42. doi: 10.1111/bcp.15199.
  • Akakpo JY, Ramachandran A, Duan L, et al. Delayed treatment with 4-methylpyrazole protects against acetaminophen hepatotoxicity in mice by inhibition of c-jun n-terminal kinase. Toxicol Sci. 2019;170(1):57–68. doi: 10.1093/toxsci/kfz077.
  • Morrison EE, Oatey K, Gallagher B, et al. Principal results of a randomized open label exploratory, safety and tolerability study with calmangafodipir in patients treated with a 12 h regimen of N-acetylcysteine for paracetamol overdose (POP trial). EBioMedicine. 2019;46:423–430. doi: 10.1016/j.ebiom.2019.07.013.
  • Routledge P, Vale JA, Bateman DN, et al. Paracetamol (acetaminophen) poisoning. BMJ. 1998;317(7173):1609–1610.
  • Sivilotti MLA, Green TJ, Langmann C, et al. Multiplying the serum aminotransferase by the acetaminophen concentration to predict toxicity following overdose. Clin Toxicol. 2010;48(8):793–799. doi: 10.3109/15563650.2010.523829.
  • Bateman DN, Dear JW. Limitations of AST/ALT ratio in paracetamol poisoning. Clin Toxicol. 2015;53(6):580–580. doi: 10.3109/15563650.2015.1027904.
  • Daly FFS, Fountain JS, Murray L, et al. Guidelines for the management of paracetamol poisoning in Australia and New Zealand - Explanation and elaboration. Med J Aust. 2008;188(5):296–301. doi: 10.5694/j.1326-5377.2008.tb01625.x.
  • Chiew AL, Reith D, Pomerleau A, et al. Updated guidelines for the management of paracetamol poisoning in Australia and New Zealand. Med J Aust. 2020;212(4):175–183. doi: 10.5694/mja2.50428.
  • Bateman DN, Dear JW, Carroll R, et al. Impact of reducing the threshold for acetylcysteine treatment in acute paracetamol poisoning: the recent United Kingdom experience. Clin Toxicol. 2014;52(8):868–872. doi: 10.3109/15563650.2014.954125.
  • Narayan H, Thomas SHL, Eddleston M, et al. Disproportionate effect on child admissions of the change in medicines and healthcare products regulatory agency guidance for management of paracetamol poisoning: an analysis of hospital admissions for paracetamol overdose in England and Scotland. Br J Clin Pharmacol. 2015;80(6):1458–1463. doi: 10.1111/bcp.12779.
  • Heard KJ, Green JL, James LP, et al. Acetaminophen-cysteine adducts during therapeutic dosing and following overdose. BMC Gastroenterol. 2011;11(1):20–21. 9. doi: 10.1186/1471-230X-11-20.
  • James LP, Letzig L, Simpson PM, et al. Pharmacokinetics of acetaminophen-protein adducts in adults with acetaminophen overdose and acute liver failure. Drug Metab Dispos. 2009;37(8):1779–1784. doi: 10.1124/dmd.108.026195.
  • Curry SC, Padilla-Jones A, Ruha AM, et al. The relationship between circulating acetaminophen-protein adduct concentrations and alanine aminotransferase activities in patients with and without acetaminophen overdose and toxicity. J Med Toxicol. 2019;15(3):143–155. doi: 10.1007/s13181-019-00705-2.
  • Wong A, Heard K, Graudins A, et al. Adducts post acetaminophen overdose treated with a 12-hour vs 20-hour acetylcysteine infusion. J Med Toxicol. 2020;16(2):188–194. doi: 10.1007/s13181-020-00757-9.
  • Arnold CG, Dylla L, Monte AA, et al. Metabolomic evaluation of N-acetyl-p-benzoquinone imine protein adduct formation with therapeutic acetaminophen administration: sex-based physiologic differences. J Med Toxicol. 2022;18(4):297–310. doi: 10.1007/s13181-022-00903-5.
  • Dear JW, Clarke JI, Francis B, et al. Risk stratification after paracetamol overdose using mechanistic biomarkers: results from two prospective cohort studies. Lancet Gastroenterol Hepatol. 2018;3(2):104–113. 3 doi: 10.1016/S2468-1253(17)30266-2.
  • Humphries C, Dear JW. Novel biomarkers for drug-induced liver injury. Clin Toxicol. 2023;61(8):567–572. doi: 10.1080/15563650.2023.2259089.
  • Llewellyn HP, Vaidya VS, Wang Z, et al. Evaluating the sensitivity and specificity of promising circulating biomarkers to diagnose liver injury in humans. Toxicol Sci. 2021;181(1):23–34. doi: 10.1093/toxsci/kfab003.
  • Roychoudhury A, Dear JW, Kersaudy-Kerhoas M, et al. Amplification-free electrochemical biosensor detection of circulating microRNA to identify drug-induced liver injury. Biosens Bioelectron. 2023;231:115298.
  • Dear JW, Bateman DN. Developing new antidotes for poisons with existing effective treatments: a case study of fomepizole in paracetamol poisoning. Clin Toxicol. 2023;61(8):577–580. doi: 10.1080/15563650.2023.2259085.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.